Enter Natco Pharma at around Rs 700: Praful Bohra

Praful Bohra, Sr Research Analyst- Pharmaceuticals at Nirmal Bang Institutional Equities suggests to enter Natco Pharma at around Rs 700.

Praful Bohra, Sr Research Analyst- Pharmaceuticals at Nirmal Bang Institutional Equities told CNBC-TV18, "Assuming that  Natco Pharma go ahead with an at risk launch, the price point currently around Rs 700 is a very good price to enter the stock because we are really bullish on Copaxone materializing, the management was pretty optimistic on getting an approval for Copaxone before somewhere around May time frame."

"If these guys really get an approval before that because Copaxone is going to be an exclusive drug for at least 2-3 years. It would be like a 3-4 player market. So, for a company of Natco's size this would be really big. So, we are really bullish on the prospects of Copaxone plus the other pipeline which they have. So Rs 700 would be an excellent price to enter," he added.

Anda sedang membaca artikel tentang

Enter Natco Pharma at around Rs 700: Praful Bohra

Dengan url

http://untukkesehatanda.blogspot.com/2014/04/enter-natco-pharma-at-around-rs-700.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Enter Natco Pharma at around Rs 700: Praful Bohra

namun jangan lupa untuk meletakkan link

Enter Natco Pharma at around Rs 700: Praful Bohra

sebagai sumbernya